News
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site will, too.
Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside ...
Green Matters on MSN6d
Ozempic Sparks Both Weight Loss Success Stories and Major Lawsuits in 2025
The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...
(Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback